Humana Inc. (HUM) Research Coverage Started at Cantor Fitzgerald

Humana Inc. (HUM) Research Coverage Started at Cantor Fitzgerald

Cantor Fitzgerald initiated coverage on shares of Humana Inc. (NYSE:HUM) in a research note released on Monday. The brokerage issued a neutral rating and a $186.00 price objective on the insurance provider’s stock.

“Digging out of the hole it created. As HUM contemplated the ACA several years ago, it chose to invest heavily in the individual exchange market. Simply put, it did not work for many reasons. After reporting substantial losses, the company decided to dramatically pare back its offerings in 2017 to reduce losses. While the repeal/replacement of ACA remains an uncertainty, it should not have much of an impact on Humana at this juncture.”,” Cantor Fitzgerald’s analyst commented.

A number of other equities analysts have also recently issued reports on the stock. Piper Jaffray Companies started coverage on shares of Humana in a research note on Tuesday, January 3rd. They issued an overweight rating and a $231.00 price objective on the stock. Jefferies Group LLC reaffirmed a buy rating and issued a $206.00 price objective on shares of Humana in a research note on Monday, November 7th. J P Morgan Chase & Co raised shares of Humana from a neutral rating to an overweight rating and raised their price objective for the company from $163.00 to $202.00 in a research note on Thursday, November 10th. Argus reaffirmed a hold rating on shares of Humana in a research note on Wednesday, January 18th. Finally, Credit Suisse Group raised shares of Humana from a neutral rating to an outperform rating and raised their price objective for the company from $175.00 to $210.00 in a research note on Friday, November 11th. Eight research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Humana has an average rating of Buy and a consensus price target of $210.40.

Humana (NYSE:HUM) opened at 199.64 on Monday. Humana has a 1-year low of $150.00 and a 1-year high of $217.80. The firm has a market capitalization of $29.77 billion, a P/E ratio of 27.00 and a beta of 0.91. The stock has a 50 day moving average of $201.51 and a 200-day moving average of $187.57.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 8th. The insurance provider reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.05 by $0.04. The business earned $12.88 billion during the quarter, compared to analyst estimates of $13.55 billion. Humana had a net margin of 2.00% and a return on equity of 12.32%. Humana’s revenue for the quarter was up .7% compared to the same quarter last year. During the same quarter last year, the business posted $1.45 earnings per share. On average, equities research analysts anticipate that Humana will post $9.52 earnings per share for the current year.

A number of large investors have recently modified their holdings of HUM. LS Investment Advisors LLC raised its position in Humana by 1.2% in the second quarter. LS Investment Advisors LLC now owns 5,144 shares of the insurance provider’s stock valued at $925,000 after buying an additional 63 shares in the last quarter. Huntington National Bank raised its position in Humana by 3.1% in the second quarter. Huntington National Bank now owns 16,134 shares of the insurance provider’s stock valued at $2,902,000 after buying an additional 491 shares in the last quarter. BP PLC purchased a new position in Humana during the second quarter valued at $3,426,000. 1ST Source Bank raised its position in Humana by 4.8% in the second quarter. 1ST Source Bank now owns 1,532 shares of the insurance provider’s stock valued at $276,000 after buying an additional 70 shares in the last quarter. Finally, Aberdeen Asset Management PLC UK raised its position in Humana by 0.4% in the second quarter. Aberdeen Asset Management PLC UK now owns 62,023 shares of the insurance provider’s stock valued at $11,157,000 after buying an additional 220 shares in the last quarter. Hedge funds and other institutional investors own 92.74% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Related posts

Leave a Comment